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ABSTRACT
Introduction: Multimodal pain therapy (MPT) has been
established accounting for biopsychosocial consideration
in diagnostic and therapy. MPT seems to be effective, but
comparability of studies is limited due to diversity of
study designs and outcome measurements. The
presented study aims to develop a core outcome set
consisting of a minimum of outcome measures deemed
necessary for medical and therapeutic decision-making,
which must be measured in all clinical trials and non-
randomised intervention studies.
Methods and analysis: The study consists of several
parts. First, the development and recommendation of
preliminary core outcome domains will be based on
results of a systematic review and structured online
surveys. Participants of the expert panel are
representatives of methodological, medical,
physiotherapeutic, psychotherapeutic profession and
patients suffering from chronic pain (n=25).
Subsequently, candidate instruments to measure
preliminary core outcome domains will be
recommended by these experts. Therefore, systematic
reviews on measurement properties of preliminary
outcome measures will be conducted and finalised in a
consensus meeting. Consented instruments and lacking
psychometric properties of relevant instruments will be
addressed and validated in the following part,
a prospective multicentre study in multimodal pain
centres on approximately 300 patients with chronic
pain. Based on all previous results, a core outcome set
for MPT measured in effectiveness studies and daily
recordkeeping will be finalised by consensus. Statistical
analyses will be performed according to methodological
standards (COSMIN).
Ethics and dissemination: The methods and
procedure of the study are developed in compliance
with the ethical principles of the Helsinki Declaration
and Good Epidemiologic Practice. Recruitment of study
participants will require approval of the study by the
responsible ethics committee and signed informed
consent from each participant. Pseudonymised data will
be used for statistical analysis.
INTRODUCTION
In Europe, approximately 11 million patients
suffer from chronic pain,1 which is deﬁned
as recurrent or permanent pain of at least
3 months with considerable impairment of
physical and psychological functioning. Pain
management approaches underwent a sig-
niﬁcant change of paradigm during the past
decades. Usually common monomodal
therapy is focused on single treatment
approaches such as pharmacological treat-
ment, physical therapy or invasive therapy.
Mayer and Gatchel2 ﬁrst developed a multi-
professional treatment approach in pain
management consisting of physical exercises
and a behavioral-psychological approach
(functional restoration, FR). Based on this
initial description of multidisciplinary pain
management, a task force of the German
IASP Chapter deﬁned multimodal pain
therapy (MPT) as the simultaneous, context-
ual, temporal and coordinated, comprehen-
sive strategy to treat chronic pain patients. It
incorporates different somatic, functional
and psychological treatment approaches with
identical aims of the therapeutic team.3 The
improvement of objective and subjective
function of the patient with increased con-
trollability and the sense of competence is
the central aim.3 There is convincing evi-
dence of effectiveness of both programmes,
FR and MPT2 4–7 in chronic pain so far.
However, the comparability of those studies
is limited due to the diversity of study design
and outcome measurement methodology.
The current lack of standardised and valid
outcome measures across trials is a barrier to
perform meta-analyses on the efﬁcacy and
effectiveness of MPT/FR and thus to practice
evidence-based pain management. Despite
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ongoing discussions concerning appropriate outcome
measures of pain therapy during the past years,8–10 a
multiperspective consensus on the most relevant out-
comes for MPT/FR is lacking.
The development of a core outcome set (COS) has
been pioneered by OMERACT (Outcome Measures in
Rheumatology11). Since then, outcome domains have
recently been deﬁned for different medical conditions
such as chronic pain in general, eczema, psoriatic arth-
ritis and ankylosing spondylitis.10 12–14 Despite ambitions
to prepare guidance on the development of COS, there
is limited standardised instruction in the literature
regarding methodological approaches.15 16
It is observable that the development of a COS begins
frequently with a systematic review of all outcomes
reported in clinical trials and a subsequent multidiscip-
linary expert panel to vote for relevant outcome
domains which should be assessed in clinical trials. Less
common, recommendations for valid and reliable meas-
urement instruments for each suggested outcome
domain are described.17
As deﬁned by Boers et al,18 outcome measures should
adequately meet the criteria of truth (ie, validity;
measure what they intend to measure), discrimination (ie,
reliability and sensitivity to change; discriminate between
situations) and feasibility (ie, be applied and interpreted
easily) in order to be meaningful and relevant.
According to the notion that studies are only as credible
as their outcome measures18 and that measures have to
be validated on target population,19 there is a high need
to clarify the relevance and validity of outcome measures
for MPT/FR.
With the initiative of IMMPACT (initiative on
methods, measurement and pain assessment in clinical
trials) the discussion about COS in the therapy of
chronic pain has been established following the
example of OMERACT.9 IMMPACT (a group of clini-
cians, researchers, representatives of a patient self-help
organisation, of governmental agencies and pharmaceut-
ical industry) deﬁned COS for all forms of chronic pain
therapies but focused on medication and clinical trials,9
not on comprehensive therapy approaches such as
MPT/FR. Another initiative has done similar work con-
sidering low back pain.20 Multidimensional tools such as
TOPS (Treatment Outcomes in Pain Survey instru-
ments21) or the standard questionnaire of the German
Pain Society22 have been developed but those processes
were not consensus driven. Further to ensure translation
from research into health provision, it seems to be
necessary to have a speciﬁc amount of domains which
cover COS in both settings, clinical trials and daily
recordkeeping. This should help to clarify the differ-
ences between controlled and natural therapy condition
and therapy outcome.
After deﬁning important outcome domains by patients
with chronic pain23 it became obvious, that these
domains did not match with the core set of outcome
domains originally deﬁned by IMMPACT.10 This gap
between clinicians/researchers’ opinion and the opinion
of the patients’ has not been closed yet, nor has been
conducted a content validation of the COS on target
population in general (chronic pain patients). According
to COSMIN,19 a COS has to be validated in target popu-
lation and in (therapy) setting as well. Therefore, there
are two main reasons to validate a COS in MPT/FR
1. MPT/FR patients have a long experience of ongoing
pain with many unsuccessful therapeutic approaches.
Pain has generalised and interferes with most of live
domains.
2. Primary aim of MPT/FR is not reduction of pain in
ﬁrst place but focuses on general improvement of
physical and psychological functioning.
The lack of validation in general, the existing gap
between patient perspective on COS in chronic pain trials
and the special character of MPT/FR do not allow to just
take over any COS without investigation. Therefore, the
VAPAIN-initiative tries to enlighten these questions in the
setting of MPT/FR and under the perspective of content
validity by both patients and clinicians.
Aims of the study
We propose an international, multiprofessional
evidence-based and evidence building consensus study
to deﬁne patient-relevant COS measurements for MPT/
FR which includes systematic reviews and systematic pro-
cedures (consensus) together with inclusion of patient
groups to enhance quality and acceptance of results and
recommendations.
The overall aim of this study is to develop an evidence-
based consensus on a COS measurement tool for MPT/
FR to assess the effectiveness of interventions and to be
used in daily recordkeeping.
To achieve the overall aim, the following speciﬁc objectives
need to be answered successively:
1. Development and recommendation of a preliminary
core set of outcome domains for effectiveness studies
and daily recordkeeping,
2. Deﬁnition of speciﬁc reliable and valid instruments
to measure the preliminary developed and recom-
mended domains for evaluation of the effectiveness
of MPT/FR,
3. Validating the preliminary core set of outcome
domains and core set of measurement instruments in
case of lacking information concerning psychometric
properties in a multicentre study in the setting of
MPT/FR,
4. Finalisation of core set of outcome domains inclusive
instruments and additional evaluation of further
questions.
METHODS AND ANALYSIS
Given the complexity of the four speciﬁc aims, a multi-
step process using a multimethod approach is necessary.
The steps of the study are shown in ﬁgure 1. The
process of achieving consensus on the ﬁnal COS is pre-
sented in ﬁgure 2.
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Step 1: Aim—development and recommendation of a
preliminary core set of outcome domains
To achieve this aim, a systematic review on effectiveness
studies using established evidence-based methods24 and
a subsequent online survey will be conducted.
Methods
Systematic review on published outcomes in effectiveness
studies of MPT/FR in chronic pain
To systematically search for incorporated domains in
randomised controlled trials and longitudinal non-
randomised studies in the matter of MPT/FR, the fol-
lowing inclusion criteria will be applied:
▸ Population: chronic pain of at least 3 -month dur-
ation; patients of all ages;
▸ Intervention: MPT/FR/comprehensive pain therapy/
rehabilitation;
▸ Comparison: not applicable;
▸ Outcome: all outcomes (syn.: end points) to be mea-
sured in assessment of chronic pain as well as applied
instruments. Study design: clinical trials and longitu-
dinal non-randomised studies with at least n=15;
▸ Publication type: full-text articles published in
English or German language.
Literature search: The systematic literature search will be
performed in MEDLINE, EMBASE and AMED. The
Figure 1 Presentation of the
multimethod approach of VAPAIN
and chronology of the several
steps. COS, core outcome set;
FR, functional restoration; MPT,
multimodal pain therapy.
Figure 2 Process of consensus and criteria of decision to include outcome domains and measurement instruments into COS.
COS, core outcome set; MPT, multimodal pain therapy.
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electronic search will be completed by hand search of
articles cited in thematically relevant reviews.
Screening and data extraction: Screening of titles/abstracts
as well as eligible full texts will be done independently
by two researchers. All disagreements will be resolved in
consensus meetings. Study characteristics and outcomes
will be extracted by using standardised evidence tables.
Outcome domains which are mentioned in at least 10%
of the included studies will be extracted.
Critical appraisal: This ﬁrst systematic review will focus
solely on broad information of used and published
outcome domains in effectiveness studies of MPT/FR in
chronic pain. The function of this review will be explora-
tory and structuring only. Appraisal of study quality and
of outcome or effectiveness of MPT/FR is not intended.
Online consensus on preliminary COS to assess
effectiveness of MPT/FR in chronic pain
In relation to the derived literature-based outcome
domains, an online survey will be conducted to recom-
mend important outcome domains for a COS.
Participants: In order to allow multiprofessional collab-
oration and to represent different stakeholder groups,
the complete consensus process with structured itera-
tive discussion and consensus voting will consist of 25
experts with methodological, clinical, medical, func-
tional and psychological expertise as well as patient
representatives.
Study procedures: Important pain societies (eg, European
Federation of IASP-Chapters, International Association
for the Study of Pain) and stakeholder groups will be
invited to nominate experts of outcome measurement in
general and of outcome measurement in chronic pain
in particular to participate.
All two rounds of the preliminary consensus process will
be performed online.
▸ First round: Based on the above described systematic
review, panel members will be asked to rate the
importance of the patient-relevant outcome domains
to assess the effectiveness of MPT/FR on a nine-point
Likert scale in the context of (1) effectiveness studies
and (2) daily recordkeeping. Scores of 1–3 will repre-
sent a region where participants believe the domain
is not important; 4–6 a region of equivocal value; and
7–9 a region where they feel the domain is import-
ant.25 Participants will be asked to list additional
outcome domains they consider as potentially rele-
vant to include into the COS, and additionally name
the number of lowest/highest reasonable amount of
domains included in the COS.
▸ Second round: Participants will receive feedback on
their own response along with the group opinion for
each domain from the previous round. Respondents
will be able to submit new scores or leave their scores
unchanged and also rate domains which were added
by participants in the ﬁrst round. Further, they are
asked to order domains from highest on to lowest
interest to be included in the COS for effectiveness
studies and daily recordkeeping.
Definition of preliminary consensus)
Online survey round 1: Consensus that an outcome domain
is important for MPT/FR and shall be discussed as poten-
tial core outcome will be deﬁned as a median score of ≥7
(see ﬁgure 2). The amount of minimum number of
necessary outcome domains in COS in clinical trials resp.
daily recordkeeping will be estimated by median.
Online survey round 2: Preliminary consensus that an
outcome domain is supposed to be part of the COS will
be deﬁned by frequency of announcing by participants
voting ‘yes/no’.
Output
The output of this consensus part is a preliminary
consensus of a core set of outcome domains for MPT/FR
in (1) effectiveness studies and (2) daily recordkeeping.
Step 2: Aim—recommendation of candidate instruments
to measure the preliminary core outcome domains from
step 1
Methods
Systematic reviews on measurement properties of
preliminary COS
The objectives of this review are to systematically assess
psychometric properties of instruments to measure the
previously deﬁned core outcome domains. Articles in
which a relevant scale depending on the particular
domain (see step 1) was published ﬁrst (inauguration
articles) and articles which subsequently investigate the
measurement properties of relevant scales are eligible.
To be included into the systematic review following
inclusion criteria will be applied.
▸ Population: chronic pain of at least 3 -month dur-
ation; patients of all ages
▸ Intervention: not applicable
▸ Comparison: not applicable
▸ Outcome: all outcome domains rated as core
outcome domains in step 2
▸ Study design: validation studies (with at least one of
the following measurement properties: content valid-
ity, internal consistency, reproducibility (test-retest
reliability, inter-observer reliability), responsiveness/
sensitivity to change, interpretability and acceptabil-
ity/ease of use)
▸ Publication type: full-text articles published in
English or German language
Literature search: The systematic literature search will be
performed within our review team in MEDLINE and
EMBASE from inception until 15 July 2014. The precise
PubMed search ﬁlter for ﬁnding studies on measure-
ment properties developed by Terwee et al26 will be used
to identify relevant articles.
Study selection and data abstraction: Screening of titles/
abstracts as well as eligible full texts will be done inde-
pendently by at least two reviewers. All disagreements
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will be resolved in consensus meetings. Study character-
istics will be extracted independently by using standar-
dised evidence tables. Evidence tables will include:
reference, geographical location, setting, study type, key
characteristics of study paricipants, name of scale,
domains and items measured.
Methodological assessment: The COSMIN checklist27 28 will
be used to evaluate the methodological quality of
included studies.
Rating of scale quality: The predeﬁned criteria of rating
scale quality are in accordance with the recommenda-
tions of the COSMIN group29 and the OMERACT ﬁlter.31
Generating recommendations for the use of identiﬁed instru-
ments: For each instrument identiﬁed in the review, a
standardised recommendation for usage or required
future validation work will be made depending on the
scale quality and on the methodological quality of
included studies.
Consensus meeting on (candidate) instruments
Presence meeting: A consensus conference for group dis-
cussion and ﬁnal voting will be scheduled in Dresden
(Germany) and all participants of step 1 will be invited.
In this ﬁnal round, according to the results of the
online surveys, the experts vote for domains being part
of the COS. Discussion of results will be moderated by
an experienced moderator. Further resulting from the
systematic reviews from step 2, the experts will be asked
to discuss and recommend particular instruments for
speciﬁc domains. At the end of the meeting, recommen-
dations on a feasible amount of domains and speciﬁc
instruments to evaluate effectiveness/daily recordkeep-
ing of MPT/FR are expected. Additionally, recommen-
dations on important gaps considering psychometric
properties of instruments and questions to be clariﬁed
by the following study/further research will be given.
Deﬁnition of consensus: Consensus that a domain/instru-
ment is important for MPT/FR will be deﬁned by at
least 70% of all members voting ‘yes’ and not more than
20% voting ‘no’.
Output
Output of step 2 is a consensus on core domains and
instruments. We further expect the nomination of
candidate instruments which shall be addressed for
further questions of research to assess their psychomet-
ric properties during the next phase of the study—the
validation of the set of instruments in a multicentre
study.
Step 3: Aim—validation of a preliminary COS of
measurement instruments to assess effectiveness of MPT/
FR in chronic pain from step 2
Methods
Prospective multicenter study in four German
comprehensive pain centers and focus groups
The core set of outcome domains and measurement
instruments recommended by the ﬁnal voting of expert
panel as described at the end of step 2 will be applied
and further investigated according to validity, reliability,
responsiveness and interpretability as highly recom-
mended psychometric properties by COSMIN19 in the
setting of MPT/FR. Instruments lacking of at least one
of the relevant psychometric properties or which have
not been investigated in the setting of MPT/FR will be
taken into step 3. To ensure complete content validity
additionally to the quantitative part of validation via
questionnaire, a qualitative part will be conducted. The
validation part will be registered as complete study
protocol.
Study population: All patients fulﬁlling the following inclu-
sion criteria: age ≥18 years, chronic permanent or recur-
rent pain for at least 3 months, medium or high
impairment of physical and psychological functioning,
sufﬁcient capability to tolerate physical activation, and
sufﬁcient skills in German language assessed by an inter-
disciplinary team in one of four cooperating German
comprehensive pain centre. Further to be included into
the qualitative validation study (focus groups), patients
have to have completed a MPT/FR programme and
have to be discharged at least for 3 months and not
more than 9 months.
Quantitative validation study
Sample size calculation: The prospective cohort study will
be exploratory and the choice of outcome measures is
yet to be determined. Such a situation does not apply
to typical sample size calculations, but we expect a
required sample size of about 190 patients (expected
effect sizes of f2=0.15 (medium effect as usually
expected for criterion of clinical important amount of
change) for multiple regression analyses under the con-
dition of α=0.05 and 1−β=0.80 (as commonly deﬁned)).
Considering a dropout from at least 20% and missing
data from at least 20%, we will recruit a total number of
270 patients.
Procedure: All consecutive patients eligible for MPT/FR
will be asked to participate in the prospective cohort
study at admission in one of the four participating
centres (Mainz, Erlangen, Dresden, Leipzig). Study
participants will be recruited over a 1-year period and
followed for 9 months. Data collection by means of
patient and physician questionnaires will be done at
baseline (admission), discharge, booster (a repetition
therapy after some weeks off therapy) and at 9 months
follow-up. The patients’ questionnaire will cover infor-
mation on sociodemographic characteristics and the
patient-reported outcome measures as deﬁned in steps 1
and 2 of the project. The physicians’ questionnaire will
cover information on physical, functional and psycho-
logical status of the patient, the patients’ history of
chronic pain and previous and current treatments.
The decision of variables matching the criterion of
good quality27 will be supported by multitrait-
multimethod approach.30 Data collection will be
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performed by each participating centre from admission
to follow-up.
Analysis: In accordance with the recommendations of
the COSMIN group,19 the following properties of
outcome measures will be considered: validation
(content), reliability (internal consistency, test-retest),
interpretability and responsiveness.
Aspects of validity and interpretability will be esti-
mated by several forms of regression analyses (multiple,
hierarchical, etc) and correlation matrix to picture
multitrait-multimethod matrix.30 Internal consistency
will be performed via Cronbach’s α,19 test-retest reliabil-
ity, if necessary, via correlation analysis. Responsiveness/
sensitivity to change will be investigated by the construct
approach recommended by De Vet et al19 for studies
with no gold standard in measurement of changes by
estimating correlations of change between two similar
instruments according to speciﬁc hypothesis.
Concerning the effect sizes, f2 for regression and deter-
mination coefﬁcient for correlation will be estimated. If
there is overlap in variables, there will be an estimation
of semi partial correlations and R2 change in regression.
Methods against bias
Reduction of recall bias: We chose a prospective design to
prevent information (recall) bias. The use of validated
assessment tools and continuous monitoring/data quality
assurance will prevent other sorts of information bias.
Reduction of selection bias: The inclusion of consecutive
patients at four multimodal pain centres will reduce
selection bias. A detailed documentation of denial or
willingness to participate in the study by the patients
enables to control differences of these groups. Possible
differences between those who ﬁll in the complete study
and those who miss at least one of the assessments will
be controlled.
Reduction of interpretation bias: Gender, education, age
and the degree of chronicity will be controlled
(adjusted) and considered during analyses (by means of
stratiﬁed analysis to explore the presence of interaction/
effect modiﬁcation).
Missings: Quality assurance measures (training of staff
and monitoring) will be undertaken to assure high
quality of data and to minimise the occurrence of
missing data. Missing outcome data in follow-up visits
will be assumed to be missing at random. Based on our
previous experiences, the follow-up rate is expected to
be at least 80%. In case of missing questionnaires,
patients will be reminded once per letter, later per tele-
phone call. Missings will be declared as two missed items
in one instrument; replacing one missing item of an
instrument by mean or median depends on the instruc-
tions of the manual.
Qualitative validation study
Because of the nature of quantitative approaches regard-
ing patient’s perspective on content validity and usability
of the instruments, there will be an additional qualitative
validation realised by focus groups (moderated group
discussions, concerning issues of content validity, respon-
siveness and usability of candidate/core instruments in
the presented study). There will be eight focus groups
(two in each of the participating centres) all consisting
of eight patients, a moderator and a transcript writer. In
order to make the different focus groups comparable,
the moderation is guided by preassigned central ques-
tions. The output of the discussion will be visualised on
presentation boards and summarised in written forms.
Both steps of documentation will be validated by the
members of the focus group to ensure internal validity.
The results of these groups will support interpretability
of the results of the quantitative study and close the gap
between clinicians’ and patients’ perspectives.
Output
Evidence of validity and reliability of core set of
outcome domains and measurement instruments in
MPT/FR will be the result of step 3. New issues of use
and psychometric properties of measurement instru-
ments will be identiﬁed and shall be addressed in the
following step 4, the ﬁnalisation of the COS of domains
and measurement instruments. The perspective of
patients will be included to ensure overlap between
experts’ and patients’ opinion about important outcome
measurement of effectiveness of MPT/FR.
Step 4: Aim—finalisation of the COS of effectiveness and
daily recordkeeping in MPT/FR by consensus
After completing the study and assembling of all concern-
ing results, a ﬁnalisation by the panel members will be
held to approve the preliminary COS or/and to develop
new questions on speciﬁc issues arising from the process.
Table 1 Abbreviations
COS Core outcome set
COMET Core outcome measures in effectiveness
trials
http://www.comet-initiative.org/
COSMIN Consensus-based standards for the selection
of health measurement instruments
http://www.cosmin.nl/
FR Functional restoration
IASP International association for the study of pain
http://www.iasp-pain.org/
IMMPACT Initiative on methods, measurement, and
pain assessment in clinical trials
http://immpact.org/
MPT Multimodal pain therapy
Synonymous: interdisciplinary,
comprehensive
OMERACT Outcome Measures in Rheumatology
http://www.omeract.org/
RCT Randomised controlled trial
TOPS Treatment outcomes in pain survey
instruments
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ETHICS AND DISSEMINATION
Ethical and legal considerations
The methods and procedure of the study are developed
in compliance with the ethical principles of the Helsinki
Declaration and Good Epidemiologic Practice.
Recruitment of study participants will require approval
of the study by the responsible ethics committee and
signed informed consent from each participant. Only
pseudonymised data will be collected in case report
forms, used in data management and throughout ana-
lyses. The study has been approved by the local ethical
committee (EK 105032015).
Qualitative assurance and safety
Pseudonymised data will be used for statistical analysis.
To ensure quality of study and analyses, there will be an
advisory board consisting of at least six experts of each
subject (psychological, medical, functional, methodo-
logical and consumer, please see online supplementary
appendix 1) who are not involved into the process of
study. Meetings will be held at least three times during
the complete study. Manual plausibility checks and statis-
tical analyses on data consistency will be done to ensure
data validity.
Use and implementation of the results
Because of the multiprofessional nature of the study
including different stakeholders (physicians, psy-
chotherapists, physiotherapists, methodologists, consu-
mers) and recruiting centres, we are conﬁdent that the
research results will be accepted and implemented in
routine care. Further, it will enable comparability
between facilities and study results and therefore
enhance decision-making for healthcare providers.
TIME FRAME
Start of part 1 was 1 January 2014 (see ﬁgure 1).
Conduction of the consensus process will start in April
2014. The ﬁnal meeting is scheduled for November
2014. Ethical commitments of the validation study in
part 2 will be ﬁnished by December 2014/January 2015.
Start of recruitment for validation study will be in
January/February 2015. Final follow-up questionnaires
will be collected until June 2016 and end of study will
be at the end of 2016 (tables 1 and 2).
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Table 2 Glossary
Term Definition
Outcome An outcome is any identified result in a domain arising from exposure to a causal factor or a health
intervention31
Domain A concept to be measured, a further specification of an aspect of health (such as health related
quality of life, illness impact, pain intensity)31
Core domain set For studies of health interventions, the minimum set of domains and subdomains necessary to
adequately cover all relevant concepts of a specific health condition within a specified setting.
Describes what to measure31
Core outcome
measurement set
The minimum set of outcome measurement instruments that must be administered in each
intervention study of a certain health condition within a specified setting to adequately cover a
corresponding core domain set. Describes how to measure31
Consensus (methods) Consensus methods derive quantitative estimates through qualitative approaches and aim to
determine the extent to which experts or lay people agree about a given issue. They consist of
following features: anonymity, iteration, controlled feedback, statistical group response25
MPT MPT is defined as a simultaneous, contextual, temporal and coordinated comprehensive strategy to
treat chronic pain patients integrating different somatic and physical, as well as psychological,
treatment approaches provided by all relevant professions (physician, psychotherapist,
physiotherapist, nurses, co therapist) with identical and consensual therapeutic aims3
FR consists of an ‘sports medicine’ approach to restore physical capacity and a cognitive ‘crisis
intervention’ technique for dealing with psychosocial issues in the patient suffering from chronic
(spinal) disability. FR teams consist of physical, occupational, and psychological therapists, nurses,
and physicians2
FR, functional restoration; MPT, multimodal pain therapy.
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commercially, and license their derivative works on different terms, provided
the original work is properly cited and the use is non-commercial. See: http://
creativecommons.org/licenses/by-nc/4.0/
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